Ready to explore whether AOD-9604 aligns with your metabolic optimization goals
Its clinical factor table says proton pump inhibitors and H2 blockers can be used alongside GLP-1 therapy if reflux emerges, and the safety section lists them plus dietary modification as parts of a gastroprotection plan
Millions of people are losing significant weight on these drugs, and the clinical data is impressive: trials like STEP 1 showed participants losing roughly 15% of total body weight over 68 weeks
Metabolic Health: Improved blood sugar control and insulin sensitivity
Quick Answer: Body odour is not an established side effect of Wegovy, though some individuals anecdotally report changes potentially linked to metabolic shifts during weight loss rather than the medication itself
This distinction, established by the Drug Quality and Security Act of 2013, defines fundamentally different levels of regulatory oversight, quality testing requirements, and manufacturing standards